ASCEND
BY NTHRYS

NTHRYSPhD AssistanceAi Targeted Delivery

Ai Targeted Delivery

Field
Category

Ai Targeted Delivery

Select a category to explore research frontiers

Ai Targeted Delivery200 categories
UIRG Unique Individual Research GapFrontier Research Gap Frontier, groups 3+ UIRGsChip badge 4 UIRGs in that frontier🔓 One fee unlocks every UIRG under a frontier🧬 Illustrated: graphical abstract published
PathFieldCategoryFrontierUIRGPhD assistance services
Targeted Delivery Foundations
Doctoral work examines directing therapeutic agents toward specific tissues or cells. Targeting raises efficacy while reducing exposure of healthy tissue.
Explore frontiers →
Drug Delivery Principle Research
Research examines fundamental principles governing how therapeutics reach their site. Delivery frequently limits efficacy more than the molecule itself.
Explore frontiers →
Targeting Concept Research
Doctoral study examines what targeting means and how it should be demonstrated. Claimed targeting frequently exceeds what evidence actually supports.
Explore frontiers →
Active Targeting Research
Research examines carriers bearing ligands binding specific cellular receptors. Active binding improves uptake once carriers reach the target tissue.
Explore frontiers →
Passive Targeting Research
Doctoral work examines accumulation arising from tissue and carrier properties alone. Passive accumulation dominates most currently approved delivery systems.
Explore frontiers →
Biodistribution Research
Research examines where administered agents actually travel within the body. Most delivered material reaches organs other than the intended target.
Explore frontiers →
Pharmacokinetic Research
Doctoral study examines absorption, distribution and elimination of delivered agents. Carrier systems change kinetics profoundly compared with free molecules.
Explore frontiers →
Clearance Mechanism Research
Research examines processes removing delivered material from the circulation. Rapid clearance prevents carriers ever reaching their intended destination.
Explore frontiers →
Renal Clearance Research
Doctoral work examines kidney filtration removing small delivered particles. A size threshold determines whether material is filtered or retained.
Explore frontiers →
Hepatic Clearance Research
Research examines the liver capturing and processing delivered carrier systems. The liver accumulates the great majority of injected nanocarriers.
Explore frontiers →
Phagocyte Uptake Research
Doctoral study examines immune cells engulfing circulating delivery carriers. Phagocytic capture is the dominant route by which carriers are lost.
Explore frontiers →
Circulation Time Research
Research examines how long carriers persist within the blood circulation. Longer circulation increases opportunity to reach the target tissue.
Explore frontiers →
Protein Corona Research
Doctoral work examines blood proteins adsorbing onto carrier surfaces immediately. The adsorbed layer determines what cells actually recognise.
Explore frontiers →
Opsonisation Research
Research examines proteins marking circulating carriers for immune removal. Opsonisation is the first step toward rapid clearance of carriers.
Explore frontiers →
Immune Recognition Research
Doctoral study examines immune responses provoked by delivery carrier systems. Recognition reduces effectiveness upon repeated administration.
Explore frontiers →
Biological Barrier Research
Research examines physiological obstacles preventing agents reaching their target. Barriers rather than potency limit most delivery approaches.
Explore frontiers →
Endothelial Barrier Research
Doctoral work examines vessel walls controlling passage into surrounding tissue. Endothelial properties differ markedly between differing organs.
Explore frontiers →
Blood Brain Barrier Research
Research examines the tight barrier excluding most agents from brain tissue. This barrier is the principal obstacle in neurological therapeutics.
Explore frontiers →
Mucosal Barrier Research
Doctoral study examines mucus layers obstructing delivery at wet body surfaces. Mucus traps and removes particles before absorption can occur.
Explore frontiers →
Epithelial Barrier Research
Research examines cell layers regulating passage across body surface linings. Epithelial junctions exclude nearly all large delivered molecules.
Explore frontiers →
Skin Barrier Research
Doctoral work examines the outer skin layer resisting penetration by agents. Skin excludes almost everything except small lipophilic molecules.
Explore frontiers →
Extracellular Matrix Barrier
Research examines dense tissue scaffolding obstructing movement of carriers. Matrix density explains poor penetration within many solid tumours.
Explore frontiers →
Interstitial Pressure Research
Doctoral study examines raised tissue pressure opposing entry of delivered agents. Elevated pressure actively pushes carriers back out of tumours.
Explore frontiers →
Tumour Microenvironment Research
Research examines conditions surrounding tumour cells affecting delivery outcomes. The environment is hostile to carriers in several distinct ways.
Explore frontiers →
Enhanced Permeability Research
Doctoral work examines leaky tumour vessels permitting carrier accumulation. This effect is highly variable and weaker in humans than in mice.
Explore frontiers →
Cellular Uptake Research
Research examines how cells internalise delivered carriers and their cargo. Reaching a tissue achieves nothing without entry into its cells.
Explore frontiers →
Endocytosis Research
Doctoral study examines cellular pathways engulfing material from outside cells. Entry route determines where cargo eventually arrives inside.
Explore frontiers →
Endosomal Escape Research
Research examines cargo leaving internal vesicles before it is destroyed. Escape efficiency is the principal bottleneck for nucleic acid delivery.
Explore frontiers →
Lysosomal Trafficking Research
Doctoral work examines material routed toward degradative cellular structures. Most internalised cargo is destroyed before it ever acts at all.
Explore frontiers →
Intracellular Targeting Research
Research examines directing cargo toward particular structures inside cells. Many therapeutics act only at one specific subcellular location.
Explore frontiers →
Nuclear Targeting Research
Doctoral study examines delivering cargo into the cell nucleus itself. Nuclear entry is required for many genetic therapeutic approaches to work.
Explore frontiers →
Mitochondrial Targeting Research
Research examines directing agents toward cellular energy producing structures. Mitochondrial targeting suits several metabolic and cancer approaches.
Explore frontiers →
Subcellular Localisation Research
Doctoral work examines determining where delivered cargo actually ends up. Localisation measurement requires imaging at demanding spatial resolution.
Explore frontiers →
Receptor Biology Research
Research examines cell surface molecules exploited as delivery targets. Receptor behaviour determines whether binding produces internalisation.
Explore frontiers →
Receptor Expression Research
Doctoral study examines how target receptor levels differ between tissues. Expression on healthy tissue limits achievable delivery selectivity.
Explore frontiers →
Target Identification Research
Research examines finding molecules suitable for directing delivery systems. Good targets are abundant on diseased and scarce on healthy cells.
Explore frontiers →
Target Validation Research
Doctoral work examines confirming a proposed target behaves as expected. Validation failure is a common and expensive cause of programme failure.
Explore frontiers →
Binding Affinity Research
Research examines strength of interaction between ligands and their targets. Higher affinity is not always better for penetration into tissue.
Explore frontiers →
Avidity Research
Doctoral study examines combined binding strength from multiple simultaneous contacts. Multivalent binding vastly exceeds single interaction strength.
Explore frontiers →
Ligand Density Research
Research examines how many targeting molecules a carrier surface should bear. Excess ligand accelerates clearance without improving targeting.
Explore frontiers →
Specificity Research
Doctoral work examines whether delivery reaches intended cells rather than others. Specificity claims require comparison against untargeted controls.
Explore frontiers →
Off Target Research
Research examines delivered agents acting where they were never intended. Off target exposure determines the toxicity that a therapy causes.
Explore frontiers →
Selectivity Index Research
Doctoral study examines quantifying preference for target over healthy tissue. Selectivity measurement is inconsistently defined across this literature.
Explore frontiers →
Therapeutic Window Research
Research examines the gap between effective and harmful exposure levels. Widening this gap is the entire central purpose of targeted delivery.
Explore frontiers →
Dose Response Research
Doctoral work examines relationships between administered quantity and effect. Carrier systems complicate the dose relationships free agents show.
Explore frontiers →
Carrier Design Research
Research examines engineering vehicles that transport therapeutic cargo safely. Carrier properties determine every aspect of delivery behaviour.
Explore frontiers →
Liposome Research
Doctoral study examines lipid vesicles enclosing therapeutic cargo within them. Liposomes were the first nanocarriers to reach clinical approval.
Explore frontiers →
Lipid Nanoparticle Research
Research examines lipid based particles carrying genetic therapeutic material. These particles enabled the first widely deployed genetic medicines.
Explore frontiers →
Ionisable Lipid Research
Doctoral work examines lipids charged only under acidic internal conditions. Charge switching is what enables escape from internal vesicles.
Explore frontiers →
Polymeric Nanoparticle Research
Research examines particles built from synthetic or natural polymer chains. Polymer chemistry permits tuning degradation and release behaviour.
Explore frontiers →
Delivery Polymer Chemistry
Doctoral study examines synthesising polymers suited to therapeutic delivery. Polymer structure governs degradation, toxicity and cargo release.
Explore frontiers →
Micelle Research
Research examines self assembling structures carrying poorly soluble agents. Micelles solubilise molecules that water alone cannot dissolve.
Explore frontiers →
Dendrimer Research
Doctoral work examines precisely branched molecules used as delivery carriers. Their exact structure permits very controlled surface modification.
Explore frontiers →
Hydrogel Research
Research examines water swollen networks releasing agents across time. Hydrogels suit local delivery where an implant can actually be placed.
Explore frontiers →
Nanogel Research
Doctoral study examines very small hydrogel particles carrying therapeutic cargo. Nanogels combine gel behaviour with injectable particle size.
Explore frontiers →
Inorganic Carrier Research
Research examines mineral and metallic particles used for delivery. Inorganic carriers raise persistent questions about eventual elimination.
Explore frontiers →
Silica Carrier Research
Doctoral work examines porous silica particles loaded with therapeutic agents. High porosity permits carrying substantial quantities of cargo.
Explore frontiers →
Gold Carrier Research
Research examines gold particles used for both delivery and local heating. Optical properties support therapy and imaging together simultaneously.
Explore frontiers →
Iron Oxide Carrier Research
Doctoral study examines magnetic particles guided and imaged using applied fields. Magnetic behaviour permits both external guidance and tracking.
Explore frontiers →
Carbon Carrier Research
Research examines carbon based structures used to transport therapeutics. Persistence within tissue raises unresolved long term safety questions.
Explore frontiers →
Protein Carrier Research
Doctoral work examines proteins used as vehicles for therapeutic cargo. Protein based carriers are inherently degradable within the human body.
Explore frontiers →
Albumin Carrier Research
Research examines the most abundant blood protein used as a delivery carrier. Albumin based delivery has already achieved clinical approval.
Explore frontiers →
Exosome Research
Doctoral study examines naturally released vesicles adapted for therapeutic delivery. Natural origin may reduce the immune recognition synthetic carriers provoke.
Explore frontiers →
Extracellular Vesicle Research
Research examines cell released particles used to transport therapeutic cargo. Production consistency is the principal obstacle to clinical use.
Explore frontiers →
Cell Membrane Coating
Doctoral work examines wrapping particles in membranes taken from living cells. Membrane coating disguises carriers from immune surveillance.
Explore frontiers →
Cell Based Delivery Research
Research examines living cells carrying therapeutic agents toward their targets. Cells navigate toward disease sites that carriers cannot find.
Explore frontiers →
Bacterial Delivery Research
Doctoral study examines engineered bacteria delivering agents to disease sites. Some bacteria colonise tumour regions that circulation cannot reach.
Explore frontiers →
Viral Vector Research
Research examines modified viruses delivering genetic material into cells. Viral vectors achieve efficiency that synthetic systems rarely match.
Explore frontiers →
Nonviral Vector Research
Doctoral work examines synthetic systems delivering genetic therapeutic material. Synthetic vectors avoid immune problems that viral vectors face.
Explore frontiers →
Nucleic Acid Delivery
Research examines transporting genetic material into cells intact and functional. Genetic cargo is fragile and cannot cross membranes unaided.
Explore frontiers →
Messenger Rna Delivery
Doctoral study examines delivering instructions for cells to make proteins. This approach reached enormous scale within recent vaccine deployment.
Explore frontiers →
Interfering Rna Delivery
Research examines delivering molecules that silence particular gene expression. Delivery difficulty long prevented this approach reaching patients.
Explore frontiers →
Gene Editing Delivery
Doctoral work examines delivering machinery that modifies genetic sequences. Delivery is now the principal obstacle facing genetic correction.
Explore frontiers →
Antisense Delivery Research
Research examines delivering short sequences that modify gene expression. Chemical modification improves stability and complicates delivery.
Explore frontiers →
Protein Delivery Research
Doctoral study examines delivering intact functional proteins to their targets. Proteins are fragile and degrade very rapidly within the body.
Explore frontiers →
Peptide Delivery Research
Research examines delivering short amino acid chains as therapeutic agents. Peptides are cleared extremely rapidly without protective carriers.
Explore frontiers →
Antibody Drug Conjugate
Doctoral work examines antibodies chemically joined to potent therapeutic agents. These constructs deliver toxic payloads directly to tumour cells.
Explore frontiers →
Linker Chemistry Research
Research examines chemical bridges joining targeting molecules to their payloads. Linker stability determines where the payload is actually released.
Explore frontiers →
Payload Research
Doctoral study examines the therapeutic agents carried by targeting constructs. Payload potency must match the small quantity actually delivered.
Explore frontiers →
Conjugation Chemistry Research
Research examines chemical methods joining therapeutic agents to their carriers. Conjugation must not destroy the function of either component.
Explore frontiers →
Site Specific Conjugation
Doctoral work examines attaching payloads at precisely defined molecular positions. Defined attachment produces far more consistent product batches.
Explore frontiers →
Small Molecule Conjugate
Research examines small targeting molecules joined to therapeutic payloads. Small constructs penetrate tissue better than antibody based ones.
Explore frontiers →
Polymer Drug Conjugate
Doctoral study examines therapeutics attached along a polymer backbone chain. Polymer attachment lengthens circulation and modifies distribution.
Explore frontiers →
Prodrug Research
Research examines inactive forms converted into active agents at the target. Conversion at the site confines activity to where it is wanted.
Explore frontiers →
Bioresponsive Prodrug Research
Doctoral work examines inactive forms activated by conditions at the target. Activation may depend upon enzymes, acidity or oxidative state.
Explore frontiers →
Targeting Ligand Research
Research examines molecules that direct carriers toward chosen cell types. Ligand choice determines both selectivity and manufacturing difficulty.
Explore frontiers →
Antibody Fragment Ligand
Doctoral study examines shortened antibody portions used as targeting ligands. Smaller fragments penetrate tissue better than whole antibodies.
Explore frontiers →
Aptamer Ligand Research
Research examines folded nucleic acid sequences binding selected targets. Aptamers are synthesised chemically rather than produced biologically.
Explore frontiers →
Peptide Ligand Research
Doctoral work examines short sequences directing carriers toward their targets. Peptide ligands are small, cheap and comparatively unstable.
Explore frontiers →
Small Molecule Ligand
Research examines small chemical entities used to direct delivery carriers. Small ligands are stable, inexpensive and very simple to attach.
Explore frontiers →
Carbohydrate Ligand Research
Doctoral study examines sugar structures binding particular cellular receptors. Sugar targeting achieves striking selectivity for liver cells.
Explore frontiers →
Folate Targeting Research
Research examines exploiting a vitamin receptor abundant on some tumours. This receptor is among the most studied delivery targets available.
Explore frontiers →
Transferrin Targeting Research
Doctoral work examines exploiting iron transport receptors for delivery. These receptors support attempts to cross into brain tissue directly.
Explore frontiers →
Integrin Targeting Research
Research examines adhesion receptors elevated on tumour blood vessels. Vessel targeting reaches tumours without penetrating the tissue itself.
Explore frontiers →
Stimuli Responsive Research
Doctoral study examines carriers releasing cargo in response to a trigger. Triggered release confines drug activity to the intended location.
Explore frontiers →
Acidity Responsive Research
Research examines carriers responding to locally acidic tissue conditions. Tumours and internal vesicles are both measurably more acidic than blood.
Explore frontiers →
Redox Responsive Research
Doctoral work examines carriers responding to differing oxidative conditions. Intracellular conditions differ sharply from those in circulation.
Explore frontiers →
Enzyme Responsive Research
Research examines carriers releasing cargo when specific enzymes are present. Enzyme patterns differ measurably between diseased and healthy tissue.
Explore frontiers →
Temperature Responsive Research
Doctoral study examines carriers releasing cargo when warmed past a threshold. Applied heating confines release to one specific chosen region.
Explore frontiers →
Light Responsive Research
Research examines carriers activated by illumination at chosen wavelengths. Light penetration limits this approach to accessible body sites.
Explore frontiers →
Ultrasound Responsive Research
Doctoral work examines sound energy triggering release from delivery carriers. Ultrasound penetrates deeply and can be focused very precisely.
Explore frontiers →
Magnetic Targeting Research
Research examines external fields concentrating carriers at chosen locations. Field strength falls rapidly and limits reachable tissue depth.
Explore frontiers →
Electric Field Research
Doctoral study examines applied electrical fields assisting delivery across barriers. Fields transiently open pathways that normally exclude agents.
Explore frontiers →
Controlled Release Research
Research examines governing the rate at which cargo leaves its carrier. Release rate determines the exposure profile tissue actually experiences.
Explore frontiers →
Sustained Release Research
Doctoral work examines maintaining agent levels across extended time periods. Sustained delivery reduces how often patients must be treated.
Explore frontiers →
Pulsatile Release Research
Research examines carriers releasing cargo in separated discrete bursts. Pulsatile patterns suit hormones and other rhythmically needed agents.
Explore frontiers →
Depot Formulation Research
Doctoral study examines injected reservoirs releasing agents over long periods. Depot delivery greatly improves adherence for chronic treatment.
Explore frontiers →
Implant Delivery Research
Research examines placed devices releasing therapeutic agents within tissue. Implants permit very long delivery and do require a surgical procedure.
Explore frontiers →
Microneedle Research
Doctoral work examines tiny projections delivering agents through the skin. Microneedles avoid pain while crossing the outermost skin barrier.
Explore frontiers →
Device Assisted Delivery
Research examines equipment improving delivery beyond formulation alone. Devices contribute where chemistry cannot overcome a physical barrier.
Explore frontiers →
Intravenous Delivery Research
Doctoral study examines agents administered directly into the bloodstream. Intravenous administration reaches everywhere and targets nowhere.
Explore frontiers →
Subcutaneous Delivery Research
Research examines agents injected beneath the skin for gradual absorption. This route permits self administration outside clinical settings.
Explore frontiers →
Oral Delivery Research
Doctoral work examines agents swallowed and then absorbed through the gut. Oral delivery is preferred by patients and is hardest to achieve.
Explore frontiers →
Gastrointestinal Absorption
Research examines how agents cross the lining of the digestive tract wall. Absorption varies enormously along the entire length of the whole gut.
Explore frontiers →
Pulmonary Delivery Research
Doctoral study examines agents delivered into the lungs by direct inhalation. Lungs offer enormous surface area and extremely thin barriers.
Explore frontiers →
Inhalation Formulation Research
Research examines preparing agents suited to delivery by inhaled aerosol. Particle size determines where within the airway material deposits.
Explore frontiers →
Nasal Delivery Research
Doctoral work examines agents administered across the lining of the nose. Nasal delivery is rapid and avoids first passage through the liver.
Explore frontiers →
Nose To Brain Delivery
Research examines agents reaching the brain along nerves from the nose. This route bypasses the barrier that excludes most delivered agents.
Explore frontiers →
Transdermal Delivery Research
Doctoral study examines agents absorbed across intact skin into the circulation. Transdermal delivery suits only a narrow range of molecules.
Explore frontiers →
Ocular Delivery Research
Research examines delivering agents to the various tissues within the eye. Tears and blinking remove most applied material almost immediately.
Explore frontiers →
Intravitreal Delivery Research
Doctoral work examines injection directly into the interior of the eye. This route is effective and requires repeated and invasive procedures.
Explore frontiers →
Otic Delivery Research
Research examines delivering agents to structures within the inner ear. Inner ear access is obstructed by membranes and by surrounding bone.
Explore frontiers →
Oral Mucosal Delivery
Doctoral study examines absorption through the lining of the whole mouth. Mouth absorption avoids both the stomach acid and liver processing.
Explore frontiers →
Vaginal Delivery Research
Research examines agents administered across the vaginal mucosal surface. This route serves both local and systemic therapeutic purposes alike.
Explore frontiers →
Rectal Delivery Research
Doctoral work examines agents administered across the rectal lining tissue. This route serves patients unable to swallow their own medication.
Explore frontiers →
Intrathecal Delivery Research
Research examines agents placed directly into the fluid surrounding nerves. This route bypasses the barrier that protects the nervous system.
Explore frontiers →
Intratumoural Delivery Research
Doctoral study examines injecting agents directly into a tumour mass. Direct injection achieves concentration that circulation cannot deliver.
Explore frontiers →
Intraarticular Delivery Research
Research examines agents injected into joint spaces for local effect. Joint injection concentrates treatment and the material clears rapidly.
Explore frontiers →
Cardiac Local Delivery
Doctoral work examines delivering agents directly to heart muscle tissue. Local cardiac delivery avoids exposing the whole body unnecessarily.
Explore frontiers →
Local Delivery Research
Research examines confining treatment to one region rather than the body. Local delivery is the simplest and most reliable form of targeting.
Explore frontiers →
Oncology Application Research
Doctoral study examines targeted delivery within the treatment of cancer. Cancer has driven the great majority of all delivery research effort.
Explore frontiers →
Solid Tumour Targeting
Research examines reaching tumours that form a distinct solid tissue mass. Solid tumours present barriers that circulating cancers simply do not.
Explore frontiers →
Blood Cancer Targeting
Doctoral work examines targeting cancers circulating within blood and marrow. Circulating targets are reachable without crossing tissue barriers.
Explore frontiers →
Metastasis Targeting Research
Research examines reaching cancer that has spread to distant body organs. Spread disease causes most cancer deaths and receives less attention.
Explore frontiers →
Tumour Penetration Research
Doctoral study examines agents moving inward from vessels through tumour tissue. Penetration failure leaves inner tumour regions entirely untreated.
Explore frontiers →
Immunotherapy Delivery Research
Research examines delivering agents that direct immune responses against disease. Local delivery may avoid the toxicity systemic immunotherapy causes.
Explore frontiers →
Vaccine Delivery Research
Doctoral work examines carriers presenting antigens to the immune system. Delivery method strongly determines the immune response that follows.
Explore frontiers →
Adjuvant Delivery Research
Research examines substances that strengthen responses to delivered antigens. Combining antigen and adjuvant within one carrier improves responses.
Explore frontiers →
Lymphatic Targeting Research
Doctoral study examines directing agents into the lymph nodes and vessels. Lymph nodes are where immune responses are actually generated at all.
Explore frontiers →
Inflammation Targeting Research
Research examines directing agents toward inflamed regions of body tissue. Inflamed vessels leak and permit accumulation much as tumours do.
Explore frontiers →
Autoimmune Application Research
Doctoral work examines targeted delivery within autoimmune disease treatment. Targeting could avoid the broad suppression current treatment causes.
Explore frontiers →
Cardiovascular Application
Research examines targeted delivery within heart and circulatory disease. Targeting diseased vessel regions remains genuinely very difficult.
Explore frontiers →
Neurological Application Research
Doctoral study examines delivering agents to the brain and nervous system. Barrier crossing is the defining difficulty within this whole area.
Explore frontiers →
Neurodegenerative Application
Research examines delivery for progressive conditions affecting the brain. Chronic treatment demands routes tolerable across many treatments.
Explore frontiers →
Infection Application Research
Doctoral work examines directing agents toward sites of active infection. Targeting could reduce the resistance that broad exposure encourages.
Explore frontiers →
Antimicrobial Delivery Research
Research examines carriers delivering agents against bacterial infection. Carriers can reach organisms that hide away inside the host cells.
Explore frontiers →
Antiviral Delivery Research
Doctoral study examines delivering agents to tissues harbouring viral infection. Some viral reservoirs are unreachable by conventional treatment.
Explore frontiers →
Metabolic Application Research
Research examines targeted delivery within metabolic disease treatment. Liver targeting is comparatively easy and clinically well established.
Explore frontiers →
Bone Targeting Research
Doctoral work examines directing agents toward mineralised skeletal tissue. Bone binding molecules provide unusually reliable tissue targeting.
Explore frontiers →
Kidney Targeting Research
Research examines delivering agents selectively to kidney tissue structures. Kidney targeting exploits the filtration that these organs perform.
Explore frontiers →
Liver Targeting Research
Doctoral study examines delivering agents selectively to liver cell populations. Natural liver accumulation makes this the easiest organ to target.
Explore frontiers →
Lung Targeting Research
Research examines delivering agents selectively to lung tissue regions. Lungs can be reached by inhalation or through the blood circulation.
Explore frontiers →
Cardiac Targeting Research
Doctoral work examines directing agents selectively toward heart muscle. Continuous motion complicates any accumulation within cardiac tissue.
Explore frontiers →
Muscle Targeting Research
Research examines delivering agents to skeletal muscle throughout the body. Muscle is a very large tissue and difficult to reach selectively.
Explore frontiers →
Ophthalmic Application Research
Doctoral study examines targeted delivery within the treatment of eye disease. Sustained ocular delivery would replace repeated painful injections.
Explore frontiers →
Dermatological Application
Research examines delivering agents to skin layers for local treatment. Local skin delivery avoids exposing the whole body quite needlessly.
Explore frontiers →
Paediatric Application Research
Doctoral work examines delivery systems suited to infants and to children. Children need differing doses, formulations and acceptable routes.
Explore frontiers →
Older Adult Application Research
Research examines delivery considerations within older patient populations. Ageing changes clearance, tissue structure and treatment tolerance.
Explore frontiers →
Pregnancy Application Research
Doctoral study examines delivery that avoids or deliberately reaches the placenta. Placental transfer determines risk to the developing baby.
Explore frontiers →
Rare Disease Application
Research examines delivery for conditions affecting very few patients. Small populations make the development economics extremely challenging.
Explore frontiers →
Theranostic Research
Doctoral work examines systems combining treatment with diagnostic imaging together. Combination confirms delivery reached the intended target tissue.
Explore frontiers →
Imaging Agent Delivery
Research examines targeted delivery of substances that make tissue visible. Targeted imaging improves both detection and treatment planning.
Explore frontiers →
Radiotherapeutic Delivery
Doctoral study examines carrying radioactive agents directly to diseased tissue. Targeted radiation treats disease that surgery cannot reach.
Explore frontiers →
Combination Delivery Research
Research examines delivering several therapeutic agents within one system. Combination permits attacking disease through differing mechanisms.
Explore frontiers →
Codelivery Research
Doctoral work examines carriers releasing several agents in coordinated fashion. Coordinated timing may matter as much as the agents themselves.
Explore frontiers →
In Vitro Model Research
Research examines laboratory systems used to assess delivery performance. Simple systems poorly predict what actually happens inside a body.
Explore frontiers →
Cell Culture Model Research
Doctoral study examines cultured cells used to evaluate carrier uptake. Flat cultures lack the barriers that real living tissue does present.
Explore frontiers →
Organoid Model Research
Research examines three dimensional tissue models assessing delivery behaviour. Organoids reproduce penetration barriers that flat cultures cannot.
Explore frontiers →
Microphysiological Model
Doctoral work examines miniature systems reproducing tissue and flow conditions. Flow reproduces forces that entirely static cultures do omit.
Explore frontiers →
Animal Model Research
Research examines living systems used to evaluate delivery before patients. Animal predictions have repeatedly proven unreliable for nanocarriers.
Explore frontiers →
Model Translation Research
Doctoral study examines whether laboratory findings predict human outcomes. Translation failure is the defining problem within this whole field.
Explore frontiers →
Species Difference Research
Research examines delivery behaviour differing between animals and humans. Tumour vessel leakiness differs profoundly between mice and people.
Explore frontiers →
Imaging Evaluation Research
Doctoral work examines tracking where delivered material actually travels. Imaging provides distribution evidence that tissue sampling cannot.
Explore frontiers →
Quantification Method Research
Research examines measuring how much agent reaches the intended target tissue. Reported delivery percentages are frequently very small indeed.
Explore frontiers →
Analytical Characterisation
Doctoral study examines measuring the properties of delivery systems produced. Characterisation is prerequisite for both approval and comparison.
Explore frontiers →
Physicochemical Characterisation
Research examines size, charge and surface properties of delivery carriers. These properties determine nearly all subsequent biological behaviour.
Explore frontiers →
Carrier Stability Research
Doctoral work examines delivery systems retaining properties across time. Instability during storage undermines otherwise effective formulations.
Explore frontiers →
Storage Research
Research examines conditions under which delivery products remain acceptable. Cold storage requirements severely constrain global distribution.
Explore frontiers →
Manufacturing Research
Doctoral study examines producing delivery systems consistently and at scale. Manufacturing difficulty prevents many promising systems reaching patients.
Explore frontiers →
Scale Up Research
Research examines moving production from laboratory toward commercial quantities. Properties frequently change when production scale increases.
Explore frontiers →
Process Control Research
Doctoral work examines maintaining consistency throughout manufacturing operations. Small process variation produces large differences in behaviour.
Explore frontiers →
Quality Attribute Research
Research examines which measured properties actually predict clinical performance. Attribute selection determines what manufacturing must control.
Explore frontiers →
Batch Consistency Research
Doctoral study examines variation between separately manufactured production batches. Complex carriers are far harder to reproduce than simple molecules.
Explore frontiers →
Delivery Sterility Research
Research examines producing injectable delivery systems free from organisms. Many carriers cannot tolerate conventional sterilisation approaches.
Explore frontiers →
Toxicology Research
Doctoral work examines harm caused by carriers as well as by their cargo. Carrier materials can themselves produce unexpected toxic effects.
Explore frontiers →
Immunotoxicity Research
Research examines immune reactions provoked by delivery carrier systems. Reactions to carrier materials have halted whole clinical programmes.
Explore frontiers →
Biocompatibility Research
Doctoral study examines whether materials are tolerated by living tissue. Tolerance must be demonstrated for every material within a system.
Explore frontiers →
Long Term Safety Research
Research examines effects of materials persisting within the body indefinitely. Persistent carriers raise concerns that short studies cannot resolve.
Explore frontiers →
Machine Learning Applications
Doctoral work applies learned models across delivery design and prediction. Learned models require validation on genuinely independent formulations.
Explore frontiers →
Formulation Prediction Research
Research examines computationally predicting how formulations will behave. Prediction could reduce the enormous experimental effort required.
Explore frontiers →
Model Validation Research
Doctoral study examines testing predictive models against independent measurements. Published models rarely report genuinely external validation.
Explore frontiers →
Clinical Translation Research
Research examines moving delivery systems from laboratory toward patients. Very few published systems ever reach any clinical evaluation at all.
Explore frontiers →
Trial Design Research
Doctoral work examines designing studies evaluating targeted delivery in patients. Demonstrating targeting benefit requires carefully chosen comparators.
Explore frontiers →
Regulatory Research
Research examines approval requirements applying to complex delivery products. Requirements are less settled than those for simple molecules.
Explore frontiers →
Standards Research
Doctoral study examines agreed methods for characterising delivery systems. Inconsistent measurement obstructs comparison between published studies.
Explore frontiers →
Cost And Access Research
Research examines affordability of advanced delivery based therapeutics. Sophisticated delivery raises cost and restricts who receives treatment.
Explore frontiers →
Low Resource Application
Doctoral work examines delivery suited to constrained healthcare settings. Simple stable formulations deliver most benefit within these settings.
Explore frontiers →
Workforce And Skills Research
Research examines expertise required across delivery research and manufacture. Combined chemistry, biology and engineering expertise is scarce.
Explore frontiers →
Economic Evaluation Research
Doctoral study examines value delivered by targeted rather than conventional treatment. Targeting must justify substantial additional development cost.
Explore frontiers →
Implementation And Adoption
Research examines why delivery advances reach patients or fail to do so. Manufacturing feasibility governs adoption as much as biological performance.
Explore frontiers →